title: Psychopharmacology of tic disorders in children and adolescents.
abstract: Tics in children and adolescents are a common occurrence; however, a small proportion of these disorders require pharmacologic interventions. Several limitations exist with the use of pharmacologic interventions, and hence, a more ideal multidisciplinary approach is recommenced, with emphasis on nonpharmacologic management for improved functioning, adaptation, and comorbidities. Mutual and realistic goals ensure a trustful and successful relationship between the clinician and patient. An individualized plan is recommended with the goal of limiting side effects and managing comorbid conditions as a priority before addressing the tics specifically. This article reviews medications used to treat tic disorders in children and adolescents.
authors.affiliation: Division of Pediatric Neurology, Michigan State University, Helen DeVos Children's Hospital, Grand Rapids, MI 49503, USA. Madeline.Chadehumbe@devoschildrens.org
authors.forename: Madeline A
authors.initials: MA
authors.lastname: Chadehumbe
authors.forename: Donald E
authors.initials: DE
authors.lastname: Greydanus
authors.forename: Cynthia
authors.initials: C
authors.lastname: Feucht
authors.forename: Dilip R
authors.initials: DR
authors.lastname: Patel
mesh_terms: D000293:Adolescent; D000322:Adrenergic Agonists / Q000627:therapeutic use; D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use; D002648:Child; D018492:Dopamine Antagonists / Q000627:therapeutic use; D058786:GABA-B Receptor Agonists / Q000627:therapeutic use; D006801:Humans; D011600:Psychopharmacology / Q000379:methods*; D013981:Tic Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology
chemical_list: D000322:Adrenergic Agonists; D018759:Adrenergic Uptake Inhibitors; D018492:Dopamine Antagonists; D058786:GABA-B Receptor Agonists